Madrid, Spain

Julia C Pichel

This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1998-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Julia C Pichel: Innovator in Antifungal Compounds

Introduction

Julia C Pichel is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of chemistry, particularly in the development of antifungal compounds. With a total of 2 patents to her name, her work has garnered attention in the pharmaceutical industry.

Latest Patents

Among her latest patents, Julia has developed carbocyclic compounds that exhibit antifungal activity. One notable patent describes a compound of formula ##STR1## wherein Z is a tetrahydro-pyrano group selected from ##STR2##, which demonstrates enhanced efficacy when combined with other antifungal agents. Additionally, she has worked on antifungal sordaridin derivatives, further showcasing her expertise in this vital area of research.

Career Highlights

Julia C Pichel is currently associated with Glaxo Wellcome Inc., a leading pharmaceutical company known for its innovative research and development. Her role at the company allows her to contribute to groundbreaking advancements in antifungal treatments.

Collaborations

Throughout her career, Julia has collaborated with esteemed colleagues, including Juan C Cuevas Zurita and Silvestre Garcia-Ochoa Dorado. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Julia C Pichel stands out as a dedicated inventor whose work in antifungal compounds has the potential to make a significant impact on public health. Her contributions to the field are commendable, and her ongoing research promises to lead to further advancements in antifungal therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…